You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company, which launched the technology in September 2019, said in its Q4 earnings release that it received high marks from beta testers.
Japanese researchers developed a catalog of HLA alleles that they used to perform a phenome-wide association study of the MHC and about a hundred phenotypes.
Linguamatics' I2E natural language processing engine helps Sanofi match HLA alleles with multiple sclerosis and associated drug treatments.
The firm said momentum from the launch of its kidney transplant test Allosure drove the overall revenue increase.
CareDx has paid Illumina a $5 million initial payment and will pay royalties in the mid-single to low-double digits on sales of future commercialized products.
A King's College London-led team performed a genome-wide association study of kidney transplant donors and recipients.
The Boston-based startup wants to help individuals interpret their HLA data for ancestry and health, and participate in research studies.
Researchers genotyped advanced cancer patients treated with immunotherapies and found that homozygosity at HLA loci was linked to decreased survival.
In Science this week: a protective gene in C. elegans, and combining EHRs with genetic data to ID HLA-associated variants
The approach allowed the researchers to identify almost 300 HLA mutations overall, many of which they were able to validate using other methods.
President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.
Wired reports that Oxitec has now developed a genetically modified fall armyworm.
A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.
In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.